No Prescription

No Prescription
HomeAlpha IndexCategories

Allergy

Anti Bacterial

Anti Convulsants

Anti Depressants

Anti Fungal

Anti Narcoleptic

Anti Viral

Antibiotics

Arthritis

Asthma

Birth Control

Blood Pressure

Cancer

Cardiovascular

Cholesterol

Diabetes

Diuretics

Eye Drops

Gastrointestinal

Hair Care

Herbal & Diet Supplements

Men's Health

Migraines

Muscle Relaxers

Nausea & Vomiting

Other

Pain Medicine

Pet Herbal Remedies

Prescription Drugs 1

Prescription Drugs 2

Prescription Drugs 3

Prescription Drugs 4

Prescription Drugs 5

Prescription Drugs 6

Prescription Drugs 7

Prescription Drugs 8

Prescription Drugs 9

Prescription Drugs 10

Prescription Drugs 11

Prescription Drugs 12

Prescription Drugs 13

Prescription Drugs 14

Prescription Drugs 15

Prescription Drugs 16

Prescription Drugs 17

Respiratory

Skin Care

Stop Smoking

Thyroid

Weight Loss

Women's Health

No Prescription

Alphabetical Index

Categories

Glucobay Precose

No Prescription » Prescription Drugs 8 » Glucobay Precose

Medical Information:

Acarbose (AY-car-bose) is used to treat a type of diabetes mellitus called type 2 diabetes. Normally your pancreas releases insulin into the blood stream after you eat. Insulin is used by all the cells in your body to help turn the food you eat into energy. This is done by using glucose (sugar) in the blood as quick energy. When you have type 2 diabetes insulin is still produced by your pancreas but the amount of insulin produced may not be enough or your body may not be using it properly and you may still need more. Because of this the insulin is not able to lower your blood sugar properly and you will have too much sugar in your blood.

Acarbose lowers your blood sugar by preventing the breakdown of starch into sugar. It may be used alone or in combination with another type of oral diabetes medicine called a sulfonylurea.

Glucobay is an oral medication used to treat type 2 (noninsulin-dependent) diabetes when high blood sugar levels cannot be controlled by diet alone. Glucobay works by slowing the body's digestion of carbohydrates so that blood sugar levels won't surge upward after a meal. Glucobay may be taken alone or in combination with certain other diabetes medications such as Diabinese Micronase Glucophage and Insulin.Acarbose slows the digestion of carbohydrates in the body which helps control blood sugar levels.

Acarbose is used to treat type 2 diabetes. Acarbose is sometimes used in combination with insulin or other diabetes medications you take by mouth.

Treating type 2 diabetes in adults whose diabetes cannot be managed with diet alone. Acarbose may be used alone in combination with other oral diabetes medicines or with insulin.

Acarbose is a glucosidase inhibitor. It works by slowing down the enzyme that turns carbohydrates into glucose; this decreases blood sugar levels following a meal.

Buy Glucobay Precose and other Prescription Drugs 8 products online at Medstore.

Buy Online at Medstore - Click Here!

About Glucobay Precose:

Product Type: Prescription Drugs 8

Glucobay ( Precose Generic Acarbose )

Glucobay (Precose Generic Acarbose)

Precose Generic Acarbose

25mg 100mg 50mg 120 Tablets 90 Tabs Precose Generic Acarbose Glucobay

View more Prescription Drugs 8

Previous Product  Next Product

No Prescription: NEW YORK, Oct. 5, 2011 /PRNewswire via COMTEX/ -- Reportlinker.com announces that a new market research report is available in its catalogue: European Pharmaceutical Market: Strategic Assessments of Leading Suppliers http://www.reportlinker.com/p0651431/European-Pharmaceutical-Market-Strategic-Assessments-of-Leading-Suppliers.html #utm_source=prnewswire&utm_medium=pr&utm_campaign=Drug_and_Medication This report provides industry executives with strategically significant competitor information and analysis of the leading players in the European pharmaceutical market. The report provides a worldwide strategic overview of the pharmaceutical market, including: Sales forecast for major product segments: ethical, OTC, generics. Sales forecast for major drug categories: cardiovascular, gastrointestinal, antibiotic, CNS, respiratory, musculoskeletal, hormonal/genitourinary, dermatological, oncological, ophthalmic, and others. In addition, the report reviews major regulatory, technological, economic, demographic, and social trends with potentially significant impact on the market during the next five years, including discussion of such key issues as pricing, industry consolidation, market globalization, growing R&D cost, generics, as well as advances in genomics, proteomics, drug screening, tissue engineering, bioinformatics, and other technologies. The companies analyzed in this report include Abbott, AstraZeneca, Bristol-Myers Squibb, Eli Lilly, GlaxoSmithKline, Johnson & Johnson, Merck, Novartis, Pfizer, Roche, Sanofi-Aventis and Wyeth.